Inflammation-driven periostin in ECRS has contrasting effects on tissue structural integrity and osteitis

Soo-In Kim1,2,3, Min-Seok Rha1,4,5, Jinsun Kim1

  • 1The Airway Mucus Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.

PubMed
Summary

Periostin, elevated in eosinophilic chronic rhinosinusitis (ECRS), drives bone thickening and structural integrity. Targeting periostin may treat ECRS inflammation and tissue remodeling.